Continuing Medical Education
Purpose
There is no laboratory or neuroimaging test that indicates a diagnosis of dystonia. It is only through the clinical examination and an awareness of the clinical features that the diagnosis is reached. As a result, many patients with dystonia are not diagnosed in a timely fashion, leading to inappropriate referrals, excessive testing and prolonged periods without treatment.
Recommended Audience
This course is recommended for general neurologists and psychiatrists who are interested in learning more about dystonia.
Learning Objectives
At the conclusion of this workshop, participants should be able to:
- List the most frequent forms of dystonia;
- List the diagnostic criteria for dystonia;
- Describe common presenting symptoms of dystonia;
- Discuss the differential diagnosis of dystonia;
- Describe common pitfalls in diagnosing dystonia;
- Outline treatment strategies for dystonia.
Accreditation Statement
The Movement Disorder Society is accredited by the ACCME to provide continuing medical education for physicians.
Designation Statement
The Movement Disorder Society designates this activity for 6.25 AMA PRA Category 1™ Credits. Physicians should only claim credit commensurate with their extent of participation in this activity.
MDS Disclosure Policy
It is the policy of The Movement Disorder Society (MDS) to ensure balance, independence, objectivity, and scientific rigor in all MDS sponsored educational activities. All persons in control of content in any MDS sponsored activity are required to disclose to MDS and the activity audience all financial relationships with any commercial interest. Such persons include, but are not limited to: planning committee members, faculty, medical writers, joint sponsor staff (when applicable), co sponsor staff (when applicable) and MDS staff.
Relationships are defined as financial relationships in any amount occurring within the past 12 months from the signing date of the attestation. This pertains to relationships with pharmaceutical companies, biomedical device manufacturers, or other corporations whose products or services are related to the field of Movement Disorders. This disclosure will be provided to all participants prior to the beginning of the CME activity. Individuals must inform MDS of any changes in financial relationships that occur between the signing date of the attestation and the date of the activity. For an individual with no financial relationships to disclose, the learners must be informed that no financial relationships exist.
The intent of this policy is not to prevent a speaker with a conflict of interest from making a presentation. It is merely intended that any potential conflict should be identified and resolved prior to the activity, so that there is no commercial bias present in the presentation. Failure by any faculty or planning committee member to disclose all such relationships will result in their inability to participate in the CME activity.
Faculty Financial Disclosures:
Susan Bressman, MD
Dr. Bressman has indicated that she has no relevant financial relationships to disclose.
Cynthia Comella, MD
Dr. Comella has indicated that she is a consultant for Jazz Pharma, Merz, UCB, Allergan, Valeant and Cephalon, and has received research support from Ipsen, Allergan, Solstice, Novartis, Astra-Zenica, the NIH, the Dystonia Study Group, Solvay and Boehringer Ingelheim.
Paul E. Greene, MD
Dr. Greene has indicated that he has no relevant financial relationships to disclose.
Mark Lew, MD
Dr. Lew has indicated that he is a consultant for Teva, Boehringer Ingelheim, GlaxoSmithKline, Kyowa, Solstice, Novartis, SchwarzPharma, Valeant and Ipsen, has received grants/research support from Teva, Boehringer Ingelheim, GlaxoSmithKline, Solstice, Novartis, SchwarzPharma, Ipsen, Mentor and the NIH, and has received honoraria from Boehringer Ingelheim, GlaxoSmithKline, Allergan, Solstice, Novartis, Teva and Valeant.
A. P. Moore, MD, FRCP
Dr. Moore has indicated that he is a consultant for Ipsen, Allergan and Solstice/Elan, has received grants/research support and honoraria from Solstice/Elan, and has received royalties from Ipsen, Allergan and Solstice/Elan.